Pulmonx (LUNG) Shares Outstanding (2019 - 2025)

Pulmonx (LUNG) has reported Shares Outstanding (Entity) for 7 consecutive years, with $41.7 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Shares Outstanding (Entity) rose 4.74% year-over-year to $41.7 million in Q4 2025; TTM through Dec 2025 was $41.7 million, a 4.74% increase from a year earlier, with the FY2025 full-year figure at $41.7 million, up 4.74% from the prior year.
• Shares Outstanding (Entity) was $41.7 million for Q4 2025 at Pulmonx, up from $41.2 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $41.7 million in Q4 2025 and troughed at $35.8 million in Q1 2021.
• A 5-year average of $38.5 million and a median of $38.2 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) jumped 1635.08% in 2021 and climbed 1.6% in 2022, its largest moves.
• Over 5 years, Shares Outstanding (Entity) stood at $36.9 million in 2021, then advanced by 1.69% to $37.6 million in 2022, then rose by 2.56% to $38.5 million in 2023, then climbed by 3.3% to $39.8 million in 2024, then rose by 4.74% to $41.7 million in 2025.
• The last three Shares Outstanding (Entity) figures came in at $41.7 million (Q4 2025), $41.2 million (Q3 2025), and $40.7 million (Q2 2025), per Business Quant data.